📋 Tender Overview
Contract awarded for Centralized framework agreement for 24 months of supply of otcs iv/2026 { "detected_language": "romanian", "translated_text": "lot-0004, title: vitamin e 100 mg ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0006, title: fiobilin ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0009, title: acetyl salicylic acid buffered 500 mg ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0014, title: water for injectable preparations (distilled water) ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0025, title: cyclo 3 fort or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0039, title: hepatrombin 50,000 ui -gel® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0040, title: hepatrombin 50,000 ui -cream® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0041, title: larofen ®, ibuprofen ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0042, title: cutaden ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0049, title: baneocin-ung ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0055, title: panadol extra ®, paradoren ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0056, title: picoprep ® or equivalent, description: the product description, the minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications. according to the specifications, the minimum and maximum quantities both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications - chapter 9. lot-0073, title: sofargen spray or equivalent, description: the product description estimated value excluding vat: 1430352.00 ron.Centralized framework agreement for 24 months of supply of otcs iv/2026